DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2017-10-10T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,6f64774f-67ae-383c-a65f-b788a6d0905a,140,Influenza  seasonal  injectable  preservative free,136.0
2017-10-10T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,6f64774f-67ae-383c-a65f-b788a6d0905a,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2017-10-10T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,6f64774f-67ae-383c-a65f-b788a6d0905a,43,Hep B  adult,136.0
2017-10-10T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,6f64774f-67ae-383c-a65f-b788a6d0905a,114,meningococcal MCV4P,136.0
2020-10-13T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,1ea92fbd-7783-4f4e-95b6-2a27d744ab0c,140,Influenza  seasonal  injectable  preservative free,136.0
2021-04-27T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,7792802a-ed81-d1e9-f33f-ec6c37660d2b,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2021-05-25T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,4920eabc-ff01-37d5-d965-0e33418719bb,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2021-10-19T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,158a7111-f069-40c5-098c-56c49e84e1ad,140,Influenza  seasonal  injectable  preservative free,136.0
2022-10-25T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,2487b631-5efc-f4c6-7390-09de989f1bb4,140,Influenza  seasonal  injectable  preservative free,136.0
2023-10-31T16:30:28Z,1a2cee1f-e553-30a0-1894-6d57c51845eb,36fe5b16-bc73-0292-cbe0-711254ee3107,140,Influenza  seasonal  injectable  preservative free,136.0
